Literature DB >> 22746320

New insights into thrombopoiesis in neonatal sepsis.

Deena S Eissa1, Rania A El-Farrash.   

Abstract

Thrombocytopenia is one of the most frequent hematologic abnormalities in the neonatal period, affecting about 18-35% of all patients admitted to the Neonatal Intensive Care Unit (NICU), with sepsis being among the most common causes of severe neonatal thrombocytopenia. It is unclear whether decreased platelet production or increased platelet consumption contributes to thrombocytopenia of septic neonates. To answer this question, we evaluated the effects of sepsis on neonatal thrombopoiesis using a panel of tests. This prospective case-control study was conducted on 50 neonates with culture-proven sepsis admitted to NICU at the Pediatrics Department, Ain Shams University Hospitals. Thirty healthy newborns were included as controls. The enrolled neonates were subjected to detailed history taking, thorough clinical examination, and laboratory investigations including complete blood count, C-reactive protein, blood cultures, and tests of thrombopoiesis; namely serum thrombopoietin (TPO) assay, flow cytometric analysis of reticulated platelet percentage (RP%), and calculation of absolute RP counts. Septic neonates comprised 24 males and 26 females with a mean gestational age of 36.0 ± 3.1 weeks. Twenty-eight (56%) of the septic neonates were thrombocytopenic (platelets < 150 000/µl). While platelet and RP counts were decreased, TPO and RP% were increased in septic neonates compared to healthy controls. Neonates with Gram-negative sepsis had the lowest platelet and RP counts and the highest TPO and RP% followed by those with fungal septicemia. Platelet counts showed inverse correlations with TPO and RP% and direct correlation with RP count. Our findings suggest that neonates respond to sepsis by up-regulating thrombopoiesis, where thrombocytopenia ensues when the rate of platelet consumption exceeds the rate of platelet production. Simultaneous measurements of serum TPO levels and RP% are helpful in discriminating hyperdestructive from hypoplastic thrombocytopenia among septic neonates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22746320     DOI: 10.3109/09537104.2012.696748

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  7 in total

1.  Effect of Severe Maternal Iron Deficiency Anemia on Neonatal Platelet Indices.

Authors:  Sriparna Basu; Naveen Kumar; Ragini Srivastava; Ashok Kumar
Journal:  Indian J Pediatr       Date:  2015-05-19       Impact factor: 1.967

Review 2.  Neonatal Sepsis and Hemostasis.

Authors:  Dimitra Gialamprinou; Georgios Mitsiakos; Georgios N Katsaras; Christos-Georgios Kontovazainitis; Paraskevi Karagianni; Emmanuel Roilides; Gili Kenet
Journal:  Diagnostics (Basel)       Date:  2022-01-20

Review 3.  Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade.

Authors:  Daniel O'Reilly; Claire A Murphy; Richard Drew; Afif El-Khuffash; Patricia B Maguire; Fionnuala Ni Ainle; Naomi Mc Callion
Journal:  Pediatr Res       Date:  2021-10-28       Impact factor: 3.756

4.  Predictive value of red blood cell distribution width in septic shock patients with thrombocytopenia: A retrospective study using machine learning.

Authors:  Jianmin Ling; Tongzhou Liao; Yanqing Wu; Zhaohua Wang; Hai Jin; Feng Lu; Minghao Fang
Journal:  J Clin Lab Anal       Date:  2021-10-21       Impact factor: 2.352

Review 5.  Sepsis and Thrombocytopenia: A Nowadays Problem.

Authors:  Daniel A Gonzalez; Rajeswar Kumar; Saba Asif; Anoushka Bali; Ashujot Kaur Dang
Journal:  Cureus       Date:  2022-05-27

6.  Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis.

Authors:  Kansuke Koyama; Shinshu Katayama; Tomohiro Muronoi; Ken Tonai; Yuya Goto; Toshitaka Koinuma; Jun Shima; Shin Nunomiya
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

7.  Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors.

Authors:  Isabelle M C Ree; Suzanne F Fustolo-Gunnink; Vincent Bekker; Karin J Fijnvandraat; Sylke J Steggerda; Enrico Lopriore
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.